SCHEMBL3316205

SCHEMBL3316205

Nc1ccc2c(C3CN(C4CCCCC4)C3)nccc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.37
ALDH1A1 P00352 2/20 0.37
MAPT P10636 2/20 0.37
GFER P55789 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
GRM4 Q14833 1/20 0.35
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ROCK1 Q13464 6/20 0.33
ROCK2 O75116 2/20 0.33
KCNH2 Q12809 2/20 0.33
MAPK7 Q13164 1/20 0.33
PDE10A Q9Y233 2/20 0.33
PARP1 P09874 1/20 0.32
MEN1 O00255 1/20 0.32
RGS12 O14924 1/20 0.32
USP2 O75604 1/20 0.32
HTT P42858 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3311477 0.89 SLC18A3 (0.40) KDM4EALDH1A1MAPTGFERTDP1
SCHEMBL3312168 0.82 KLKB1 (0.38) ALDH1A1GRM4NPC1RAB9ASMN1; SMN2
SCHEMBL3314206 0.80 MAPK7 (0.35) KDM4EALDH1A1MAPTGFERGRM4
SCHEMBL3317150 0.78 ROCK1 (0.35) GRM4ROCK1ROCK2KCNH2MAPK7
SCHEMBL3312181 0.77 ROCK1 (0.41) KDM4EALDH1A1GRM4ROCK1ROCK2
SCHEMBL3312549 0.76 ROCK1 (0.40) KDM4EROCK1ROCK2KCNH2ACHE
SCHEMBL3316822 0.76 MAPK7 (0.34) KDM4EALDH1A1MAPTGRM4NPC1
SCHEMBL3315584 0.76 OPRL1 (0.45) ROCK1MAPK7ACHEOPRM1
SCHEMBL3320107 0.74 ROCK1 (0.34) GRM4ROCK1ROCK2KCNH2MAPK7
SCHEMBL3313673 0.74 ADORA2A (0.41) ROCK1ROCK2KCNH2GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8748614-B2 Substituted isoquinoline and isoquinolinone derivatives SANOFI (FR) 2014-06-10 US disclosed
US-20100105650-A1 Substituted isoquinoline and isoquinolinone derivatives SANOFI-AVENTIS (FR) 2010-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100105650-A1 Substituted isoquinoline and isoquinolinone derivatives MYLK2, MYLK, MYLK3 KDM4E 2111/4885ALDH1A1 2302/4885MAPT 1144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.